Novel Paradigms for Dialysis Vascular Access: Downstream Vascular Biology--is There a Final Common Pathway?

Overview

Journal Clin J Am Soc Nephrol

Specialty Nephrology

Date 2013 Aug 31

PMID 23990166

Citations 23

Authors

Timmy Lee

Affiliations

Soon will be listed here.

Abstract

Vascular access dysfunction is a major cause of morbidity and mortality in hemodialysis patients. The most common cause of vascular access dysfunction is venous stenosis from neointimal hyperplasia within the perianastomotic region of an arteriovenous fistula and at the graft-vein anastomosis of an arteriovenous graft. There have been few, if any, effective treatments for vascular access dysfunction because of the limited understanding of the pathophysiology of venous neointimal hyperplasia formation. This review will (1) describe the histopathologic features of hemodialysis access stenosis; (2) discuss novel concepts in the pathogenesis of neointimal hyperplasia development, focusing on downstream vascular biology; (3) highlight future novel therapies for treating downstream biology; and (4) discuss future research areas to improve our understanding of downstream biology and neointimal hyperplasia development.

Citing Articles

Efficacy of cutting balloon angioplasty versus high-pressure balloon angioplasty for the treatment of arteriovenous fistula stenoses in patients undergoing hemodialysis: Systematic review and meta-analysis.

Pang S, Chang T, Chang M, Huang X, Wang X, Song M PLoS One. 2024; 19(1):e0296191.

PMID: 38271445 PMC: 10810470. DOI: 10.1371/journal.pone.0296191.

Cannulation Technique of Vascular Access in Hemodialysis and the Impact on the Arteriovenous Fistula Survival: Systematic Review and Meta-Analysis.

Peralta R, Sousa L, Cristovao A J Clin Med. 2023; 12(18).

PMID: 37762887 PMC: 10532371. DOI: 10.3390/jcm12185946.

Association between preoperative C-reactive protein to albumin ratio and late arteriovenous fistula dysfunction in hemodialysis patients: a cohort study.

Hu S, Wang R, Ma T, Lei Q, Yuan F, Zhang Y Sci Rep. 2023; 13(1):11184.

PMID: 37433824 PMC: 10336133. DOI: 10.1038/s41598-023-38202-w.

Chronic Kidney Disease Transdifferentiates Veins into a Specialized Immune-Endocrine Organ with Increased MYCN-AP1 Signaling.

Saaoud F, Martinez L, Lu Y, Xu K, Shao Y, Zhuo J Cells. 2023; 12(11).

PMID: 37296603 PMC: 10252601. DOI: 10.3390/cells12111482.

Choosing the right treatment for the right lesion, part I: a narrative review of the role of plain balloon angioplasty in dialysis access maintenance.

DePietro D, Trerotola S Cardiovasc Diagn Ther. 2023; 13(1):212-232.

PMID: 36864950 PMC: 9971312. DOI: 10.21037/cdt-22-375.

References

Conte M, Nugent H, Gaccione P, Guleria I, Roy-Chaudhury P, Lawson J . Multicenter phase I/II trial of the safety of allogeneic endothelial cell implants after the creation of arteriovenous access for hemodialysis use: the V-HEALTH study. J Vasc Surg. 2009; 50(6):1359-68.e1. DOI: 10.1016/j.jvs.2009.07.108. View

Schober A . Chemokines in vascular dysfunction and remodeling. Arterioscler Thromb Vasc Biol. 2008; 28(11):1950-9. DOI: 10.1161/ATVBAHA.107.161224. View

Misra S, Fu A, Anderson J, Sethi S, Glockner J, McKusick M . The rat femoral arteriovenous fistula model: increased expression of matrix metalloproteinase-2 and -9 at the venous stenosis. J Vasc Interv Radiol. 2008; 19(4):587-94. DOI: 10.1016/j.jvir.2008.01.005. View

Charo I, Ransohoff R . The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med. 2006; 354(6):610-21. DOI: 10.1056/NEJMra052723. View

Tronc F, Mallat Z, Lehoux S, Wassef M, Esposito B, Tedgui A . Role of matrix metalloproteinases in blood flow-induced arterial enlargement: interaction with NO. Arterioscler Thromb Vasc Biol. 2000; 20(12):E120-6. DOI: 10.1161/01.atv.20.12.e120. View

Dixon B . Why don't fistulas mature?. Kidney Int. 2006; 70(8):1413-22. DOI: 10.1038/sj.ki.5001747. View

Zempo N, Koyama N, Kenagy R, Lea H, Clowes A . Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor. Arterioscler Thromb Vasc Biol. 1996; 16(1):28-33. DOI: 10.1161/01.atv.16.1.28. View

Feldman H, Joffe M, Rosas S, Burns J, Knauss J, Brayman K . Predictors of successful arteriovenous fistula maturation. Am J Kidney Dis. 2003; 42(5):1000-12. DOI: 10.1016/j.ajkd.2003.07.003. View

Li L, Terry C, Blumenthal D, Kuji T, Masaki T, Kwan B . Cellular and morphological changes during neointimal hyperplasia development in a porcine arteriovenous graft model. Nephrol Dial Transplant. 2007; 22(11):3139-46. DOI: 10.1093/ndt/gfm415. View

10.

Feldman H, Kobrin S, Wasserstein A . Hemodialysis vascular access morbidity. J Am Soc Nephrol. 1996; 7(4):523-35. DOI: 10.1681/ASN.V74523. View

11.

Dember L, Beck G, Allon M, Delmez J, Dixon B, Greenberg A . Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA. 2008; 299(18):2164-71. PMC: 4943222. DOI: 10.1001/jama.299.18.2164. View

12.

Misra S, Fu A, Anderson J, Glockner J, McKusick M, Bjarnason H . Fetuin-A expression in early venous stenosis formation in a porcine model of hemodialysis graft failure. J Vasc Interv Radiol. 2008; 19(10):1477-82. PMC: 2583174. DOI: 10.1016/j.jvir.2008.06.007. View

13.

Shi Y, OBrien Jr J, Ala-Kokko L, Chung W, Mannion J, Zalewski A . Origin of extracellular matrix synthesis during coronary repair. Circulation. 1997; 95(4):997-1006. DOI: 10.1161/01.cir.95.4.997. View

14.

Rothuizen T, Wong C, Quax P, van Zonneveld A, Rabelink T, Rotmans J . Arteriovenous access failure: more than just intimal hyperplasia?. Nephrol Dial Transplant. 2013; 28(5):1085-92. DOI: 10.1093/ndt/gft068. View

15.

Schwartz S, DeBlois D, OBrien E . The intima. Soil for atherosclerosis and restenosis. Circ Res. 1995; 77(3):445-65. DOI: 10.1161/01.res.77.3.445. View

16.

Roy-Chaudhury P, Kelly B, Miller M, Reaves A, Armstrong J, Nanayakkara N . Venous neointimal hyperplasia in polytetrafluoroethylene dialysis grafts. Kidney Int. 2001; 59(6):2325-34. DOI: 10.1046/j.1523-1755.2001.00750.x. View

17.

Rotmans J, Pattynama P, Verhagen H, Hino I, Velema E, Pasterkamp G . Sirolimus-eluting stents to abolish intimal hyperplasia and improve flow in porcine arteriovenous grafts: a 4-week follow-up study. Circulation. 2005; 111(12):1537-42. DOI: 10.1161/01.CIR.0000159332.18585.B5. View

18.

Kim H, Park S, Lee S, Shin O, Yoon S, Yang C . Arterial micro-calcification of vascular access is associated with aortic arch calcification and arterial stiffness in hemodialysis patients. Semin Dial. 2012; 26(2):216-22. DOI: 10.1111/j.1525-139X.2012.01113.x. View

19.

Diao Y, Guthrie S, Xia S, Ouyang X, Zhang L, Xue J . Long-term engraftment of bone marrow-derived cells in the intimal hyperplasia lesion of autologous vein grafts. Am J Pathol. 2008; 172(3):839-48. PMC: 2258265. DOI: 10.2353/ajpath.2008.070840. View

20.

Lee T, Roy-Chaudhury P . Advances and new frontiers in the pathophysiology of venous neointimal hyperplasia and dialysis access stenosis. Adv Chronic Kidney Dis. 2009; 16(5):329-38. PMC: 2764321. DOI: 10.1053/j.ackd.2009.06.009. View